Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types

Between 1976 and 1984 204 infections by penicillinase-producing Neisseria gonorrhoeae (PPNG) were seen in the Whitechapel Clinic. In 1984 PPNG were isolated from 4·7% of all patients attending with gonorrhoea. Three infections were homosexually acquired; 140 infections (68%) were acquired in the U.K...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 1985-01, Vol.11 (1), p.63-69
Hauptverfasser: Goh, B.T., Rodin, P., Johnston, N.A., Wong, H.H.Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue 1
container_start_page 63
container_title The Journal of infection
container_volume 11
creator Goh, B.T.
Rodin, P.
Johnston, N.A.
Wong, H.H.Y.
description Between 1976 and 1984 204 infections by penicillinase-producing Neisseria gonorrhoeae (PPNG) were seen in the Whitechapel Clinic. In 1984 PPNG were isolated from 4·7% of all patients attending with gonorrhoea. Three infections were homosexually acquired; 140 infections (68%) were acquired in the U.K. Strains that were tested were fully sensitive to spectinomycin (190), cefuroxime (177), kanamycin (170), amoxycillin combined with clavulanic acid (24) and rosoxacin (18). Of 135 strains 61% were resistant to co-trimoxazole, 69% of 169 to tetracycline (MIC ⩾ 1 mg/1) and 32% of 75 to streptomycin. Of 109 strains subjected to plasmid typing, 72(66%) were Asian strains. Of these, 55 (50% of the total) were without and 17 (16% of the total) possessed the 24·5 Mdal transfer plasmid; 27 (25%) were African strains without and 10 (9%) with the transfer plasmid. Of the Asian strains 10 were acquired in Africa. All four plasmid-containing strains are now endemic in the U.K. On the basis of the sensitivity tests, spectinomycin, cefuroxime and kanamycin should be effective in treatment, but not co-trimoxazole and tetracycline.
doi_str_mv 10.1016/S0163-4453(85)91094-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76282073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445385910941</els_id><sourcerecordid>14398587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-5dff9793268501612b6179cd7a3bf425d00bc441e056daa09c6a178b75611dc93</originalsourceid><addsrcrecordid>eNqFkVuLFDEQhYMo67j6Exb6QUTB1tw78UVk8QaLCupzSCfVY2n6YtIjzL83szPM676kHs5XlTp1CLli9BWjTL_-Xh_RSqnEc6NeWEatbNk9smFK8JZ3kt8nmzPykDwq5Tel1AqrL8iFsNx0Wm_In28wYcCUcPIF2iXPcRdw2jZfAEuBjL7ZztOc868ZPLxpYMEII85p3u5fNn5accSQ5x59asquBFhW7DHhuq9ibJbky4ixWfcLlMfkweBTgSenekl-fnj_4_pTe_P14-frdzdtkJyurYrDYDsruDaqGmC816yzIXZe9IPkKlLaBykZUKWj99QG7Vln-k5pxmKw4pI8O86tbv7uoKxuxLpZSn6CeVdcp7nhtBN3gkwKa5TpKqiOYLVaSobBLRlHn_eOUXdIw92m4Q6ndka52zQcq31Xpw92_Qjx3HU6f9WfnnRfgk9D9lPAcsaMkoaZw5i3Rwzq1f4hZFcCwhQgYoawujjjHYv8B9igqBE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14398587</pqid></control><display><type>article</type><title>Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Goh, B.T. ; Rodin, P. ; Johnston, N.A. ; Wong, H.H.Y.</creator><creatorcontrib>Goh, B.T. ; Rodin, P. ; Johnston, N.A. ; Wong, H.H.Y.</creatorcontrib><description>Between 1976 and 1984 204 infections by penicillinase-producing Neisseria gonorrhoeae (PPNG) were seen in the Whitechapel Clinic. In 1984 PPNG were isolated from 4·7% of all patients attending with gonorrhoea. Three infections were homosexually acquired; 140 infections (68%) were acquired in the U.K. Strains that were tested were fully sensitive to spectinomycin (190), cefuroxime (177), kanamycin (170), amoxycillin combined with clavulanic acid (24) and rosoxacin (18). Of 135 strains 61% were resistant to co-trimoxazole, 69% of 169 to tetracycline (MIC ⩾ 1 mg/1) and 32% of 75 to streptomycin. Of 109 strains subjected to plasmid typing, 72(66%) were Asian strains. Of these, 55 (50% of the total) were without and 17 (16% of the total) possessed the 24·5 Mdal transfer plasmid; 27 (25%) were African strains without and 10 (9%) with the transfer plasmid. Of the Asian strains 10 were acquired in Africa. All four plasmid-containing strains are now endemic in the U.K. On the basis of the sensitivity tests, spectinomycin, cefuroxime and kanamycin should be effective in treatment, but not co-trimoxazole and tetracycline.</description><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/S0163-4453(85)91094-1</identifier><identifier>PMID: 3928766</identifier><identifier>CODEN: JINFD2</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Bacteriology ; Biological and medical sciences ; Drug Combinations - pharmacology ; Drug Resistance, Microbial ; Epidemiology ; Female ; Fundamental and applied biological sciences. Psychology ; Gonorrhea - drug therapy ; Gonorrhea - epidemiology ; Humans ; Male ; Microbial Sensitivity Tests ; Microbiology ; Neisseria gonorrhoeae - drug effects ; Neisseria gonorrhoeae - enzymology ; Neisseria gonorrhoeae - genetics ; Penicillinase - biosynthesis ; Plasmids ; Streptomycin - pharmacology ; Sulfamethoxazole - pharmacology ; Tetracycline - pharmacology ; Trimethoprim - pharmacology ; Trimethoprim, Sulfamethoxazole Drug Combination</subject><ispartof>The Journal of infection, 1985-01, Vol.11 (1), p.63-69</ispartof><rights>1985 The British Society for the Study of Infection</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-5dff9793268501612b6179cd7a3bf425d00bc441e056daa09c6a178b75611dc93</citedby><cites>FETCH-LOGICAL-c420t-5dff9793268501612b6179cd7a3bf425d00bc441e056daa09c6a178b75611dc93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0163445385910941$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8548181$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3928766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goh, B.T.</creatorcontrib><creatorcontrib>Rodin, P.</creatorcontrib><creatorcontrib>Johnston, N.A.</creatorcontrib><creatorcontrib>Wong, H.H.Y.</creatorcontrib><title>Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><description>Between 1976 and 1984 204 infections by penicillinase-producing Neisseria gonorrhoeae (PPNG) were seen in the Whitechapel Clinic. In 1984 PPNG were isolated from 4·7% of all patients attending with gonorrhoea. Three infections were homosexually acquired; 140 infections (68%) were acquired in the U.K. Strains that were tested were fully sensitive to spectinomycin (190), cefuroxime (177), kanamycin (170), amoxycillin combined with clavulanic acid (24) and rosoxacin (18). Of 135 strains 61% were resistant to co-trimoxazole, 69% of 169 to tetracycline (MIC ⩾ 1 mg/1) and 32% of 75 to streptomycin. Of 109 strains subjected to plasmid typing, 72(66%) were Asian strains. Of these, 55 (50% of the total) were without and 17 (16% of the total) possessed the 24·5 Mdal transfer plasmid; 27 (25%) were African strains without and 10 (9%) with the transfer plasmid. Of the Asian strains 10 were acquired in Africa. All four plasmid-containing strains are now endemic in the U.K. On the basis of the sensitivity tests, spectinomycin, cefuroxime and kanamycin should be effective in treatment, but not co-trimoxazole and tetracycline.</description><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Drug Combinations - pharmacology</subject><subject>Drug Resistance, Microbial</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gonorrhea - drug therapy</subject><subject>Gonorrhea - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Neisseria gonorrhoeae - drug effects</subject><subject>Neisseria gonorrhoeae - enzymology</subject><subject>Neisseria gonorrhoeae - genetics</subject><subject>Penicillinase - biosynthesis</subject><subject>Plasmids</subject><subject>Streptomycin - pharmacology</subject><subject>Sulfamethoxazole - pharmacology</subject><subject>Tetracycline - pharmacology</subject><subject>Trimethoprim - pharmacology</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVuLFDEQhYMo67j6Exb6QUTB1tw78UVk8QaLCupzSCfVY2n6YtIjzL83szPM676kHs5XlTp1CLli9BWjTL_-Xh_RSqnEc6NeWEatbNk9smFK8JZ3kt8nmzPykDwq5Tel1AqrL8iFsNx0Wm_In28wYcCUcPIF2iXPcRdw2jZfAEuBjL7ZztOc868ZPLxpYMEII85p3u5fNn5accSQ5x59asquBFhW7DHhuq9ibJbky4ixWfcLlMfkweBTgSenekl-fnj_4_pTe_P14-frdzdtkJyurYrDYDsruDaqGmC816yzIXZe9IPkKlLaBykZUKWj99QG7Vln-k5pxmKw4pI8O86tbv7uoKxuxLpZSn6CeVdcp7nhtBN3gkwKa5TpKqiOYLVaSobBLRlHn_eOUXdIw92m4Q6ndka52zQcq31Xpw92_Qjx3HU6f9WfnnRfgk9D9lPAcsaMkoaZw5i3Rwzq1f4hZFcCwhQgYoawujjjHYv8B9igqBE</recordid><startdate>19850101</startdate><enddate>19850101</enddate><creator>Goh, B.T.</creator><creator>Rodin, P.</creator><creator>Johnston, N.A.</creator><creator>Wong, H.H.Y.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19850101</creationdate><title>Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types</title><author>Goh, B.T. ; Rodin, P. ; Johnston, N.A. ; Wong, H.H.Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-5dff9793268501612b6179cd7a3bf425d00bc441e056daa09c6a178b75611dc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Drug Combinations - pharmacology</topic><topic>Drug Resistance, Microbial</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gonorrhea - drug therapy</topic><topic>Gonorrhea - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Neisseria gonorrhoeae - drug effects</topic><topic>Neisseria gonorrhoeae - enzymology</topic><topic>Neisseria gonorrhoeae - genetics</topic><topic>Penicillinase - biosynthesis</topic><topic>Plasmids</topic><topic>Streptomycin - pharmacology</topic><topic>Sulfamethoxazole - pharmacology</topic><topic>Tetracycline - pharmacology</topic><topic>Trimethoprim - pharmacology</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goh, B.T.</creatorcontrib><creatorcontrib>Rodin, P.</creatorcontrib><creatorcontrib>Johnston, N.A.</creatorcontrib><creatorcontrib>Wong, H.H.Y.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goh, B.T.</au><au>Rodin, P.</au><au>Johnston, N.A.</au><au>Wong, H.H.Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>1985-01-01</date><risdate>1985</risdate><volume>11</volume><issue>1</issue><spage>63</spage><epage>69</epage><pages>63-69</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><coden>JINFD2</coden><abstract>Between 1976 and 1984 204 infections by penicillinase-producing Neisseria gonorrhoeae (PPNG) were seen in the Whitechapel Clinic. In 1984 PPNG were isolated from 4·7% of all patients attending with gonorrhoea. Three infections were homosexually acquired; 140 infections (68%) were acquired in the U.K. Strains that were tested were fully sensitive to spectinomycin (190), cefuroxime (177), kanamycin (170), amoxycillin combined with clavulanic acid (24) and rosoxacin (18). Of 135 strains 61% were resistant to co-trimoxazole, 69% of 169 to tetracycline (MIC ⩾ 1 mg/1) and 32% of 75 to streptomycin. Of 109 strains subjected to plasmid typing, 72(66%) were Asian strains. Of these, 55 (50% of the total) were without and 17 (16% of the total) possessed the 24·5 Mdal transfer plasmid; 27 (25%) were African strains without and 10 (9%) with the transfer plasmid. Of the Asian strains 10 were acquired in Africa. All four plasmid-containing strains are now endemic in the U.K. On the basis of the sensitivity tests, spectinomycin, cefuroxime and kanamycin should be effective in treatment, but not co-trimoxazole and tetracycline.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>3928766</pmid><doi>10.1016/S0163-4453(85)91094-1</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-4453
ispartof The Journal of infection, 1985-01, Vol.11 (1), p.63-69
issn 0163-4453
1532-2742
language eng
recordid cdi_proquest_miscellaneous_76282073
source MEDLINE; Elsevier ScienceDirect Journals
subjects Bacteriology
Biological and medical sciences
Drug Combinations - pharmacology
Drug Resistance, Microbial
Epidemiology
Female
Fundamental and applied biological sciences. Psychology
Gonorrhea - drug therapy
Gonorrhea - epidemiology
Humans
Male
Microbial Sensitivity Tests
Microbiology
Neisseria gonorrhoeae - drug effects
Neisseria gonorrhoeae - enzymology
Neisseria gonorrhoeae - genetics
Penicillinase - biosynthesis
Plasmids
Streptomycin - pharmacology
Sulfamethoxazole - pharmacology
Tetracycline - pharmacology
Trimethoprim - pharmacology
Trimethoprim, Sulfamethoxazole Drug Combination
title Penicillinase-producing Neisseria gonorrhoeae: epidemiology, antimicrobial susceptibility and plasmid types
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A07%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Penicillinase-producing%20Neisseria%20gonorrhoeae:%20epidemiology,%20antimicrobial%20susceptibility%20and%20plasmid%20types&rft.jtitle=The%20Journal%20of%20infection&rft.au=Goh,%20B.T.&rft.date=1985-01-01&rft.volume=11&rft.issue=1&rft.spage=63&rft.epage=69&rft.pages=63-69&rft.issn=0163-4453&rft.eissn=1532-2742&rft.coden=JINFD2&rft_id=info:doi/10.1016/S0163-4453(85)91094-1&rft_dat=%3Cproquest_cross%3E14398587%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14398587&rft_id=info:pmid/3928766&rft_els_id=S0163445385910941&rfr_iscdi=true